Home › Companies › LEXICON PHARMACEUTICALS INC. › 2023-2024
Compiled from SEC Form N-PX filings and LEXICON PHARMACEUTICALS INC.’s Form 8-K, filed 2024-05-10 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Proxy season: 2023-2024
Explore LEXICON PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are LEXICON PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-10 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Philippe J. Amouyal | 241,812,501 | -- | -- | 18,607,732 | 29,015,729 | Majority: yes |
| Elect Director: Lonnel Coats | 247,448,636 | -- | -- | 12,971,597 | 29,015,729 | Majority: yes |
| Elect Director: Diane E. Sullivan | 259,435,040 | -- | -- | 985,193 | 29,015,729 | Majority: yes |
| Elect Director: Ratification and approval of the the Company's Sixth Amended and Restated Certificate of Incorporation | 160,676,391 | 1,433,806 | 211,035 | -- | -- | Majority: yes |
Source: LEXICON PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2024-05-10 — read the filing on EDGAR.
Each item below shows how the 109 asset managers that disclosed a LEXICON PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of LEXICON PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
91% fund support · no official result
The 108 asset managers below cast 91% of the shares they voted on this item FOR (37,495,545 for, 3,636,423 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 11,998,357 | 0 | 0 | 0 | For |
| Point72 | 9,216,600 | 0 | 0 | 0 | For |
| BlackRock | 5,040,827 | 7,099 | 0 | 0 | For |
| Vanguard | 2,295,433 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 1,771,810 | 0 | 0 | 0 | For |
| State Street | 1,404,573 | 349 | 0 | 0 | For |
| Charles Schwab | 1,232,594 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 1,204,203 | 0 | 0 | Against |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 804,111 | 0 | 0 | Against |
| JPMorgan | 690,625 | 0 | 0 | 0 | For |
| Nuveen | 594,382 | 0 | 0 | 0 | For |
| TIAA | 592,572 | 0 | 0 | 0 | For |
| Wellington | 0 | 568,106 | 0 | 0 | Against |
| PINNACLE ASSOCIATES LTD | 531,690 | 0 | 0 | 0 | For |
| Northern Trust | 516,393 | 0 | 0 | 0 | For |
| Equitable | 20,371 | 219,941 | 0 | 0 | Against |
| AllianceBernstein | 0 | 219,941 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 197,839 | 0 | 0 | 0 | For |
| AMERIPRISE FINANCIAL INC | 0 | 175,849 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 101,332 | 0 | 0 | 0 | For |
| Invesco | 100,769 | 0 | 0 | 0 | For |
| BBR PARTNERS, LLC | 100,000 | 0 | 0 | 0 | For |
| Cerity Partners LLC | 0 | 95,512 | 0 | 0 | Against |
| GREAT POINT PARTNERS LLC | 92,165 | 0 | 0 | 0 | For |
Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Diane E. Sullivan”): 259,435,040 for, 985,193 withheld, per its Form 8-K filed 2024-05-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 37 asset managers below cast 100% of the shares they voted on this item FOR (12,324,218 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 2,813,804 | 0 | 0 | 0 | For |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 592,515 | 0 | 0 | 0 | For |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 240,312 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,516 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 60,801 | 0 | 0 | 0 | For |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 47,381 | 0 | 0 | 0 | For |
| Invesco | 38,591 | 0 | 0 | 0 | For |
| ProShares | 33,538 | 0 | 0 | 0 | For |
| Pacific Life | 32,246 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,636 | 0 | 0 | 0 | For |
| Brighthouse | 26,469 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,945 | 0 | 0 | 0 | For |
| DWS | 14,403 | 0 | 0 | 0 | For |
| Principal | 10,534 | 0 | 0 | 0 | For |
| Voya | 9,063 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Lonnel Coats”): 247,448,636 for, 12,971,597 withheld, per its Form 8-K filed 2024-05-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 37 asset managers below cast 100% of the shares they voted on this item FOR (11,489,113 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 2,813,804 | 0 | 0 | 0 | For |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 592,515 | 0 | Abstain |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 240,312 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,516 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 60,801 | 0 | Abstain |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 47,381 | 0 | Abstain |
| Invesco | 0 | 0 | 38,591 | 0 | Abstain |
| ProShares | 0 | 0 | 33,538 | 0 | Abstain |
| Pacific Life | 32,246 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,636 | 0 | 0 | 0 | For |
| Brighthouse | 9,582 | 0 | 16,887 | 0 | Abstain |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 14,945 | 0 | Abstain |
| DWS | 0 | 0 | 14,403 | 0 | Abstain |
| Principal | 0 | 0 | 10,534 | 0 | Abstain |
| Voya | 9,063 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Philippe J. Amouyal”): 241,812,501 for, 18,607,732 withheld, per its Form 8-K filed 2024-05-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 37 asset managers below cast 100% of the shares they voted on this item FOR (8,154,872 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 2,813,804 | 0 | Abstain |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 592,515 | 0 | Abstain |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 240,312 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 159,505 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 76,516 | 0 | Abstain |
| ETFis Series Trust I | 0 | 0 | 60,801 | 0 | Abstain |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 47,381 | 0 | Abstain |
| Invesco | 38,591 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 33,538 | 0 | Abstain |
| Pacific Life | 0 | 0 | 32,246 | 0 | Abstain |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 0 | 26,636 | 0 | Abstain |
| Brighthouse | 9,582 | 0 | 16,887 | 0 | Abstain |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 14,945 | 0 | Abstain |
| DWS | 0 | 0 | 14,403 | 0 | Abstain |
| Principal | 0 | 0 | 10,534 | 0 | Abstain |
| Voya | 0 | 0 | 9,063 | 0 | Abstain |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Ratification and approval of the the Company's Sixth Amended and Restated Certificate of Incorporation”): 160,676,391 for, 1,433,806 against, per its Form 8-K filed 2024-05-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.
The 37 asset managers below cast 100% of the shares they voted on this item FOR (12,333,085 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 2,813,804 | 0 | 0 | 0 | For |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 592,515 | 0 | 0 | 0 | For |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 240,312 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,516 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 60,801 | 0 | 0 | 0 | For |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 47,381 | 0 | 0 | 0 | For |
| Invesco | 38,591 | 0 | 0 | 0 | For |
| ProShares | 33,538 | 0 | 0 | 0 | For |
| Pacific Life | 32,246 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,636 | 0 | 0 | 0 | For |
| Brighthouse | 26,469 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,945 | 0 | 0 | 0 | For |
| DWS | 14,403 | 0 | 0 | 0 | For |
| Principal | 10,534 | 0 | 0 | 0 | For |
| Voya | 9,063 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 37 asset managers below cast 100% of the shares they voted on this item FOR (12,333,085 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 2,813,804 | 0 | 0 | 0 | For |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 592,515 | 0 | 0 | 0 | For |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 240,312 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,516 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 60,801 | 0 | 0 | 0 | For |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 47,381 | 0 | 0 | 0 | For |
| Invesco | 38,591 | 0 | 0 | 0 | For |
| ProShares | 33,538 | 0 | 0 | 0 | For |
| Pacific Life | 32,246 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,636 | 0 | 0 | 0 | For |
| Brighthouse | 26,469 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,945 | 0 | 0 | 0 | For |
| DWS | 14,403 | 0 | 0 | 0 | For |
| Principal | 10,534 | 0 | 0 | 0 | For |
| Voya | 9,063 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Ranked by the number of LEXICON PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 246,236,753 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 4.87% |
| 2 | Point72 | 3.74% |
| 3 | BlackRock | 2.05% |
| 4 | Vanguard | 0.93% |
| 5 | ORBIMED ADVISORS LLC | 0.72% |
| 6 | State Street | 0.57% |
| 7 | Charles Schwab | 0.50% |
| 8 | Columbia Threadneedle | 0.49% |
| 9 | PNC BANK, NATIONAL ASSOCIATION | 0.33% |
| 10 | JPMorgan | 0.28% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Invus, L.P., Invus Public Equities, L.P., Invus US Partners, LLC and Artal International S | 73.32% | DEF14A |
| FMR (Fidelity) | 15.71% | 13F |
| FMR LLC | 15.00% | DEF14A |
| Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Tra | 9.92% | DEF14A |
| Vanguard Group | 3.87% | 13F |
| Raymond Debbane | 2.76% | DEF14A |
| BlackRock | 1.38% | 13F |
| Geode Capital | 0.97% | 13F |
| State Street | 0.81% | 13F |
| Lonnel Coats | 0.45% | DEF14A |
Percentages above are of 246,236,753 shares outstanding, as reported by LEXICON PHARMACEUTICALS INC. on its Form 10-Q dated 2024-04-29 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LEXICON PHARMACEUTICALS INC.’s 10-Q dated 2024-04-29. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At LEXICON PHARMACEUTICALS INC.'s shareholder meeting held 2024-05-10, in the 2023-2024 proxy season, 109 asset managers reported how they voted in their SEC Form N-PX filings, covering 808 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. LEXICON PHARMACEUTICALS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Advisory vote to approve the compensation paid to the Company's named executive officers — the reporting funds cast 91% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
LEXICON PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page).